|
1
|
Rossi S, Di Narzo AF, Mestdagh P, et al:
microRNAs in colon cancer: a roadmap for discovery. FEBS Lett.
586:3000–3007. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gansler T, Ganz PA, Grant M, et al: Sixty
years of CA: a cancer journal for clinicians. CA Cancer J Clin.
60:345–350. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lamy P, Andersen CL, Dyrskjøt L, Tørring
N, Ørntoft T and Wiuf C: Are microRNAs located in genomic regions
associated with cancer? Br J Cancer. 95:1415–1418. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duisters RF, Tijsen AJ, Schroen B, et al:
miR-133 and miR-30 regulate connective tissue growth factor:
implications for a role of microRNAs in myocardial matrix
remodeling. Circ Res. 104:170–178. 6p2009. View Article : Google Scholar
|
|
5
|
Wen D, Li S, Ji F, et al: miR-133b acts as
a tumor suppressor and negatively regulates FGFR1 in gastric
cancer. Tumour Biol. 34:793–803. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu G, Chen D, Li X, Yang K, Wang H and Wu
W: miR-133b regulates the MET proto-oncogene and inhibits the
growth of colorectal cancer cells in vitro and in vivo. Cancer Biol
Ther. 10:190–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen CC and Lau LF: Functions and
mechanisms of action of CCN matricellular proteins. Int J Biochem
Cell Biol. 41:771–783. 2009. View Article : Google Scholar :
|
|
8
|
Chu CY, Chang CC, Prakash E and Kuo ML:
Connective tissue growth factor (CTGF) and cancer progression. J
Biomed Sci. 15:675–685. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garcia P, Leal P, Ili C, Brebi P, Alvarez
H and Roa JC: Inhibition of connective tissue growth factor
(CTGF/CCN2) in gallbladder cancer cells leads to decreased growth
in vitro. Int J Exp Pathol. 94:195–202. 2013.PubMed/NCBI
|
|
10
|
Kang Y, Siegel PM, Shu W, et al: A
multigenic program mediating breast cancer metastasis to bone.
Cancer Cell. 3:537–549. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deng YZ, Chen PP, Wang Y, et al:
Connective tissue growth factor is overexpressed in esophageal
squamous cell carcinoma and promotes tumorigenicity through
beta-catenin-T-cell factor/Lef signaling. J Biol Chem.
282:36571–36581. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wenger C, Ellenrieder V, Alber B, et al:
Expression and differential regulation of connective tissue growth
factor in pancreatic cancer cells. Oncogene. 18:1073–1080. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kubo M, Kikuchi K, Nashiro K, et al:
Expression of fibrogenic cytokines in desmoplastic malignant
melanoma. Br J Dermatol. 139:192–197. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shakunaga T, Ozaki T, Ohara N, et al:
Expression of connective tissue growth factor in cartilaginous
tumors. Cancer. 89:1466–1473. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee HK, Bier A, Cazacu S, et al:
MicroRNA-145 is downregulated in glial tumors and regulates glioma
cell migration by targeting connective tissue growth factor. PLoS
One. 8:e546522013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer; New York, NY: 2010
|
|
17
|
Xiang KM and Li XR: MiR-133b acts as a
tumor suppressor and negatively regulates TBPL1 in colorectal
cancer cells. Asian Pac J Cancer Prev. 15:3767–3772. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin CW, Li XR, Zhang Y, et al: TAp63
suppress metastasis via miR-133b in colon cancer cells. Br J
Cancer. 110:2310–2320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wen D, Li S, Ji F, Cao H, Jiang W, Zhu J
and Fang X: Mir-133b acts as a tumor suppressor and negatively
regulates FGFR1 in gastric cancer. Tumour Biol. 34:793–803. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Crawford M, Batte K, Yu L, Wu X, Nuovo GJ,
Marsh CB, Otterson GA and Nana-Sinkam SP: MicroRNA-133b targets
pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem
Biophys Res Commun. 388:483–489. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ichimi T, Enokida H, Okuno Y, Kunimoto R,
Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama
K, et al: Identification of novel microRNA targets based on
microRNA signatures in bladder cancer. Int J Cancer. 125:345–352.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duisters RF, Tijsen AJ, Schroen B, et al:
miR-133 and miR-30 regulate connective tissue growth factor:
implications for a role of microRNAs in myocardial matrix
remodeling. Circ Res. 104:170–178. 2009. View Article : Google Scholar
|
|
23
|
Hofmeister V, Schrama D and Becker JC:
Anti-cancer therapies targeting the tumor stroma. Cancer Immunol
Immunother. 57:1–17. 2008. View Article : Google Scholar
|
|
24
|
Wendt MK, Smith JA and Schiemann WP:
Transforming growth factor-β-induced epithelial-mesenchymal
transition facilitates epidermal growth factor-dependent breast
cancer progression. Oncogene. 29:6485–6498. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang B, Herman-Edelstein M, Koh P, Burns
W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM,
Cooper ME and Kantharidis P: E-cadherin expression is regulated by
miR-192/215 by a mechanism that is independent of the profibrotic
effects of transforming growth factor-beta. Diabetes. 59:1794–1802.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Secker GA, Shortt AJ, Sampson E, Schwarz
QP, Schultz GS and Daniels JT: TGFbeta stimulated
re-epithelialisation is regulated by CTGF and Ras/MEK/ERK
signalling. Exp Cell Res. 314:131–142. 2008. View Article : Google Scholar
|
|
27
|
Babic AM, Chen CC and Lau LF: Fisp12/mouse
connective tissue growth factor mediates endothelial cell adhesion
and migration through integrin alphavbeta3, promotes endothelial
cell survival, and induces angiogenesis in vivo. Mol Cell Bio.
19:2958–2966. 1999.
|
|
28
|
Lau LF and Lam SC: The CCN family of
angiogenic regulators: the integrin connection. Exp Cell Res.
248:44–57. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dornhöfer N, Spong S, Bennewith K, Salim
A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, et
al: Connective tissue growth factor-specific monoclonal antibody
therapy inhibits pancreatic tumor growth and metastasis. Cancer
Res. 66:5816–5827. 2006. View Article : Google Scholar : PubMed/NCBI
|
